Measurement of Tralokinumab Concentrations in Serum and Tear Fluid of Atopic Dermatitis Patients and the Relationship With Treatment Response and Ocular Surface Disease

Publication date

2025-11

Authors

Dekkers, Coco C
Smeijsters, Erin H
El Amrani, Mohsin
Den Hartog Jager, StansISNI 0000000389002215
van der Elst, Kim
van Luin, Matthijs
van Luijk, Chantal
Bakker, Daphne S
Huitema, Alwin D.R.ISNI 0000000397166009
de Graaf, MISNI 0000000395808952

Editors

Advisors

Supervisors

Document Type

Letter

Collections

Open Access logo

License

cc_by_nc_nd

Abstract

Keywords

Journal Article

Citation

Dekkers, C, Smeijsters, E H, El Amrani, M, Jager, C D H, van der Elst, K C M, van Luin, M, van Luijk, C, Bakker, D S, Huitema, A D R, de Graaf, M, van Wijk, F & de Bruin-Weller, M S 2025, 'Measurement of Tralokinumab Concentrations in Serum and Tear Fluid of Atopic Dermatitis Patients and the Relationship With Treatment Response and Ocular Surface Disease', Clinical and Experimental Allergy, vol. 55, no. 11, pp. 1156-1160. https://doi.org/10.1111/cea.70098